SE8405514L - Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning - Google Patents

Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning

Info

Publication number
SE8405514L
SE8405514L SE8405514A SE8405514A SE8405514L SE 8405514 L SE8405514 L SE 8405514L SE 8405514 A SE8405514 A SE 8405514A SE 8405514 A SE8405514 A SE 8405514A SE 8405514 L SE8405514 L SE 8405514L
Authority
SE
Sweden
Prior art keywords
alkyl
group
hydrogen
furyl
pentatomic
Prior art date
Application number
SE8405514A
Other languages
English (en)
Swedish (sv)
Other versions
SE8405514D0 (sv
Inventor
F Faustini
A Panzeri
F Orzi
Salle E Di
R Ceserani
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8405514D0 publication Critical patent/SE8405514D0/xx
Publication of SE8405514L publication Critical patent/SE8405514L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
SE8405514A 1983-11-04 1984-11-02 Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning SE8405514L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838329559A GB8329559D0 (en) 1983-11-04 1983-11-04 Furyl derivatives of 16-substituted prostaglandins preparations

Publications (2)

Publication Number Publication Date
SE8405514D0 SE8405514D0 (sv) 1984-11-02
SE8405514L true SE8405514L (sv) 1985-05-05

Family

ID=10551287

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405514A SE8405514L (sv) 1983-11-04 1984-11-02 Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning

Country Status (18)

Country Link
US (1) US4585791A (da)
JP (1) JPS60112782A (da)
AU (1) AU563999B2 (da)
BE (1) BE900959A (da)
CH (1) CH663413A5 (da)
DE (1) DE3439863A1 (da)
DK (1) DK524484A (da)
FI (1) FI844273L (da)
FR (1) FR2554448B1 (da)
GB (2) GB8329559D0 (da)
GR (1) GR80822B (da)
HU (1) HU193708B (da)
IL (1) IL73395A0 (da)
IT (1) IT1177095B (da)
NL (1) NL8403307A (da)
SE (1) SE8405514L (da)
SU (1) SU1489582A3 (da)
ZA (1) ZA848551B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834498A (en) * 1992-09-21 1998-11-10 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
US8063033B2 (en) * 2008-01-18 2011-11-22 Allergan, Inc. Therapeutic beta-lactams
US7960378B2 (en) 2008-03-18 2011-06-14 Allergan, Inc. Therapeutic compounds
EP2297085B1 (en) * 2008-04-24 2019-03-20 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
EP2297084A1 (en) * 2008-04-24 2011-03-23 Allergan, Inc. Therapeutic compounds
CA2728227A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic cyclopentane derivatives
CA2723894A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic substituted hydantoins, and related compounds
US8569349B2 (en) 2008-05-09 2013-10-29 Allergan, Inc. Therapeutic compounds
WO2009137411A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
HUE031885T2 (en) * 2012-07-19 2017-08-28 Cayman Chemical Co Inc Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
US3956284A (en) * 1972-07-13 1976-05-11 Pfizer Inc. Heterocyclic 15-substituted-ω-pentanorprostoglandins
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.

Also Published As

Publication number Publication date
DK524484D0 (da) 1984-11-02
JPS60112782A (ja) 1985-06-19
GB2149788B (en) 1987-04-08
GR80822B (en) 1985-03-04
DE3439863A1 (de) 1985-05-23
CH663413A5 (de) 1987-12-15
FI844273A0 (fi) 1984-10-31
IT8423390A0 (it) 1984-10-30
FI844273A7 (fi) 1985-05-05
IT1177095B (it) 1987-08-26
SE8405514D0 (sv) 1984-11-02
IT8423390A1 (it) 1986-04-30
GB8427678D0 (en) 1984-12-05
ZA848551B (en) 1985-06-26
AU3494584A (en) 1985-05-09
SU1489582A3 (ru) 1989-06-23
HU193708B (en) 1987-11-30
AU563999B2 (en) 1987-07-30
FR2554448B1 (fr) 1987-07-24
DK524484A (da) 1985-05-05
IL73395A0 (en) 1985-02-28
GB8329559D0 (en) 1983-12-07
NL8403307A (nl) 1985-06-03
FR2554448A1 (fr) 1985-05-10
GB2149788A (en) 1985-06-19
FI844273L (fi) 1985-05-05
BE900959A (fr) 1985-05-02
US4585791A (en) 1986-04-29
HUT35637A (en) 1985-07-29

Similar Documents

Publication Publication Date Title
ES462060A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
SE8405514D0 (sv) Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning
SE8303910D0 (sv) 15-deoxi-hydroxiprostaglandiner och forfarande for framstellning derav
GB1515414A (en) 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
EA199801000A1 (ru) Производные алкиламинобензотиазола и -бензоксазола
NO20001871L (no) Nye 3,6-hemiacetaler fra klassen 9a-azalider
SE8403801D0 (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
FR2453851A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
ES2070849T3 (es) Nuevos queladores de calcio fotosensibles.
DK1694641T3 (da) Prostaglandinsyntese
GB1448414A (en) Prostaglandin intermediates
SE7907953L (sv) Substituerade furaner
DK120483A (da) Phenylpiperazinderivater og fremgangsmaade til deres fremstilling
JPS5283396A (en) Novel compound physiologically acceptable salts thereof process for preparing same and medical composition containing same
ES439856A1 (es) Un procedimiento para la preparacion de nuevos eteres basi- cos.
ES483253A1 (es) Un procedimiento para la prepracion de derivados de pipera- zin-2,5-diona.
ES8301479A1 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ES422081A1 (es) Procedimiento para la preparacion de nuevos eteres diglici-dilicos de benzimidazolonas.
ES386554A1 (es) Procedimiento para preparar derivados de propanolamina.
US4366313A (en) 2-Decarboxy-2-tetrazolyl-6-keto-PGE1 compounds
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
ATE29496T1 (de) Tetrahydro-beta-carbolin-derivate und verfahren fuer ihre herstellung.
ES437041A1 (es) Un procedimiento para preparar derivados de 1-ftalazona.
FR2331335A2 (fr) Nouvelles prostaglandines et leur preparation

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8405514-4

Effective date: 19880531